SC-51

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameSC-51

Drug Alias NameSC-51L-NIL-TA

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNitric oxide synthase, inducible inhibitors

TargetsNitric oxide synthase, inducible

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A